| 6001 | BML-NS570-0010 | 2-Methylserotonin . HCl | 10 mg |
| 6002 | BML-NS570-0050 | 2-Methylserotonin . HCl | 50 mg |
| 6003 | BML-NS660-0100 | 1-(1-Naphthyl)piperazine . HCl | 100 mg |
| 6004 | BML-NS705-0010 | ORG-12962 | 10 mg |
| 6005 | BML-NS705-0050 | ORG-12962 | 50 mg |
| 6006 | BML-NS710-0020 | Paroxetine . HCl | 20 mg |
| 6007 | BML-NS710-0100 | Paroxetine . HCl | 100 mg |
| 6008 | BML-NS901-0005 | Y-25130 | 5 mg |
| 6009 | BML-NZ1112-0025 | Neurotensin polyclonal antibody | 25 µl |
| 6010 | BML-NZ1113-0025 | Neurotensin polyclonal antibody | 25 µl |
| 6011 | BML-P100-0001 | CaM kinase IV substrate | 1 mg |
| 6012 | BML-P101-0001 | Autocamtide-2 | 1 mg |
| 6013 | BML-P102-0001 | Syntide-2 | 1 mg |
| 6014 | BML-P103-0001 | Casein kinase II β (198-215) | 1 mg |
| 6015 | BML-P104-0500 | CSH103 substrate | 500 µg |
| 6016 | BML-P106-0001 | H1-7 | 1 mg |
| 6017 | BML-P107-0001 | Kemptide | 1 mg |
| 6018 | BML-P108-0001 | Malantide | 1 mg |
| 6019 | BML-P109-0001 | EGF receptor (651-658) | 1 mg |
| 6020 | BML-P110-0001 | Myelin basic protein (4-14) (N-acetylated) | 1 mg |
| 6021 | BML-P111-0001 | [Ser<sup>25</sup>]-Protein kinase C (19-31) | 1 mg |
| 6022 | BML-P112-0001 | BPDEtide | 1 mg |
| 6023 | BML-P114-0001 | MLCK substrate (skeletal and smooth muscle) | 1 mg |
| 6024 | BML-P115-0001 | MLCK substrate (skeletal muscle) | 1 mg |
| 6025 | BML-P118-0500 | [Ala<sup>97</sup>]-RII (81-99) | 0.5 mg |
| 6026 | BML-P120-0005 | Ac-Leu-Leu-Nle-CHO | 5 mg |
| 6027 | BML-P120-0025 | Ac-Leu-Leu-Nle-CHO | 25 mg |
| 6028 | BML-P121-0001 | EGF receptor (661-681) | 1 mg |
| 6029 | BML-P122-0001 | Myelin basic protein (95-98) S5 peptide | 1 mg |
| 6030 | BML-P123-0001 | Tyrosine hydroxylase (rat) (24-33) | 1 mg |
| 6031 | BML-P124-0001 | ERK1/ERK2 (172-190) | 1 mg |
| 6032 | BML-P125-0005 | MMP substrate (chromogenic) | 5 mg |
| 6033 | BML-P126-0001 | OMNIMMP<sup>®</sup> fluorogenic substrate | 1 mg |
| 6034 | BML-P127-0001 | OMNIMMP<sup>®</sup> fluorogenic control | 1 mg |
| 6035 | BML-P128-0001 | MMP substrate (fluorogenic) | 1 mg |
| 6036 | BML-P129-0001 | Akt substrate | 1 mg |
| 6037 | BML-P131-0001 | MMP substrate α (fluorogenic) | 1 mg |
| 6038 | BML-P132-0500 | TACE substrate (fluorogenic) | 0.5 mg |
| 6039 | BML-P133-0005 | Ac-IEPD-pNA | 5 mg |
| 6040 | BML-P134-0005 | Ac-IEPD-AMC | 5 mg |
| 6041 | BML-P135-0025 | H-Arg-AMC . 2HCl | 25 mg |
| 6042 | BML-P136-0025 | H-Arg-pNA . 2HCl | 25 mg |
| 6043 | BML-P137-0010 | Z-RR-AMC | 10 mg |
| 6044 | BML-P137-0050 | Z-RR-AMC | 50 mg |
| 6045 | BML-P138-0025 | Z-RR-pNA | 25 mg |
| 6046 | BML-P139-0010 | OMNICATHEPSIN<sup>®</sup> fluorogenic substrate | 10 mg |
| 6047 | BML-P139-0050 | OMNICATHEPSIN<sup>®</sup> fluorogenic substrate | 50 mg |
| 6048 | BML-P141-0025 | Suc-AAPF-pNA | 25 mg |
| 6049 | BML-P142-0020 | Z-GPR-AMC | 20 mg |
| 6050 | BML-P144-0001 | Ribosomal protein S6 (rat) (229-239) | 1 mg |
| 6051 | BML-P145-0001 | Cathepsin D & E substrate (fluorogenic) | 1 mg |
| 6052 | BML-P146-0001 | Casein kinase I peptide substrate | 1 mg |
| 6053 | BML-P148-0001 | IκB kinase substrate (biotinylated) | 1 mg |
| 6054 | BML-P149-0001 | Crosstide | 1 mg |
| 6055 | BML-P150-0500 | Protein kinase C (19-36) | 0.5 mg |
| 6056 | BML-P151-0001 | GSK3 substrate | 1 mg |
| 6057 | BML-P152-0001 | Protein phosphatase 2 substrate | 1 mg |
| 6058 | BML-P153-0001 | Protein tyrosine phosphatase substrate | 1 mg |
| 6059 | BML-P154-0001 | PKCδ substrate | 1 mg |
| 6060 | BML-P155-0500 | [Ser<sup>159</sup>]-PKCε (149-164) | 0.5 mg |
| 6061 | BML-P156-0001 | PKCζ substrate | 1 mg |
| 6062 | BML-P157-0001 | Shp 1 & 2 substrate | 1 mg |
| 6063 | BML-P158-0001 | Chk 1 & 2 substrate | 1 mg |
| 6064 | BML-P160-0500 | [pSer<sup>95</sup>, Ala<sup>97</sup>]-RII (81-99) | 0.5 mg |
| 6065 | BML-P161-0001 | Abz-FRK(Dnp)-P | 1 mg |
| 6066 | BML-P162-0001 | Abz-SDK(Dnp)-P | 1 mg |
| 6067 | BML-P163-0001 | Mca-APK(Dnp) | 1 mg |
| 6068 | BML-P164-0001 | [pThr<sup>183</sup>, pTyr<sup>185</sup>] MAP kinase (177-189) | 1 mg |
| 6069 | BML-P165-0001 | Z-AAD-CMK | 1 mg |
| 6070 | BML-P188-0025 | GP-pNA | 25 mg |
| 6071 | BML-P189-0005 | GP-AMC | 5 mg |
| 6072 | BML-P191-0001 | Crosstide (biotinylated) | 1 mg |
| 6073 | BML-P193-0001 | GSK-3 substrate II | 1 mg |
| 6074 | BML-P194-0001 | PAK4 & Akt substrate | 1 mg |
| 6075 | BML-P195-0001 | CREBtide | 1 mg |
| 6076 | BML-P196-0001 | MAPKAPK2 substrate | 1 mg |
| 6077 | BML-P197-0001 | Src substrate | 1 mg |
| 6078 | BML-P199-0010 | Z-VVR-AMC | 10 mg |
| 6079 | BML-P200-0500 | CaM kinase II (290-309) | 0.5 mg |
| 6080 | BML-P201-0500 | CaM kinase II (281-309) | 0.5 mg |
| 6081 | BML-P202-0500 | [Ala<sup>286</sup>]-CaM kinase II (281-302) | 0.5 mg |
| 6082 | BML-P203-0500 | PKI (5-24) | 0.5 mg |
| 6083 | BML-P204-0001 | PKI (6-22) amide | 1 mg |
| 6084 | BML-P205-0500 | Protein kinase C (20-28) (myristoylated) | 0.5 mg |
| 6085 | BML-P206-0001 | Protein kinase C (19-31) | 1 mg |
| 6086 | BML-P207-0500 | EGF receptor (651-658) (myristoylated) | 0.5 mg |
| 6087 | BML-P208-0001 | PKG inhibitor | 1 mg |
| 6088 | BML-P209-0001 | MLCK (342-352) amide | 1 mg |
| 6089 | BML-P210-0500 | PKI (14-22) amide (myristoylated) | 0.5 mg |
| 6090 | BML-P211-0001 | AIP | 1 mg |
| 6091 | BML-P212-0500 | AIP (myristoylated) | 0.5 mg |
| 6092 | BML-P213-0005 | MeOSuc-AAPV-pNA | 5 mg |
| 6093 | BML-P214-0001 | R18 peptide | 1 mg |
| 6094 | BML-P215-0001 | Fyn kinase substrate | 1 mg |
| 6095 | BML-P216-0001 | Abl kinase substrate | 1 mg |
| 6096 | BML-P217-0001 | Lyn & Syk kinase substrate | 1 mg |
| 6097 | BML-P219-0500 | PKCζ (113-125) (myristoylated) | 0.5 mg |
| 6098 | BML-P224-0005 | MeOSuc-AAPV-AMC | 5 mg |
| 6099 | BML-P225-0001 | R18 peptide (biotinylated) | 1 mg |
| 6100 | BML-P226-0001 | IKK substrate | 1 mg |
| 6101 | BML-P227-0001 | Mca-RPPGFSAFK(Dnp) | 1 mg |
| 6102 | BML-P228-0100 | TACE substrate II (fluorogenic) | 100 µg |
| 6103 | BML-P229-0010 | Z-LR-AMC | 10 mg |
| 6104 | BML-P230-0100 | Leu-pNA | 100 mg |
| 6105 | BML-P231-0001 | SAMS peptide | 1 mg |
| 6106 | BML-P232-0001 | SAMS peptide (biotinylated) | 1 mg |
| 6107 | BML-P233-0001 | SAMS peptide (phosphorylated) (biotinylated) | 1 mg |
| 6108 | BML-P234-0001 | Enterostatin (human) | 1 mg |
| 6109 | BML-P234-0005 | Enterostatin (human) | 5 mg |
| 6110 | BML-P235-0001 | ADAM substrate (fluorogenic) | 1 mg |
| 6111 | BML-P236-0025 | Met-AMC | 25 mg |
| 6112 | BML-P237-0005 | Boc-Gln-Ala-Arg-AMC | 5 mg |
| 6113 | BML-P238-0001 | NP-M2tide | 1 mg |
| 6114 | BML-P239-0001 | P-M2tide | 1 mg |
| 6115 | BML-P240-0001 | VEGFR-2 substrate | 1 mg |
| 6116 | BML-P241-0001 | VEGFR-2 substrate (biotinylated) | 1 mg |
| 6117 | BML-P242-0001 | HER2 substrate | 1 mg |
| 6118 | BML-P243-0001 | HER2 substrate (biotinylated) | 1 mg |
| 6119 | BML-P244-0001 | FGFR substrate | 1 mg |
| 6120 | BML-P245-0001 | FGFR substrate (biotinylated) | 1 mg |
| 6121 | BML-P246-0001 | Hsp27tide | 1 mg |
| 6122 | BML-P247-0001 | Hsp27tide (biotinylated) | 1 mg |
| 6123 | BML-P248-0001 | Axltide | 1 mg |
| 6124 | BML-P249-0001 | Axltide (biotinylated) | 1 mg |
| 6125 | BML-P250-0100 | PDKtide | 100 µg |
| 6126 | BML-P251-0100 | PDKtide (biotinylated) | 100 µg |
| 6127 | BML-P256-0500 | Histone H3 dimethyl lysine-4 peptide | 0.5 mg |
| 6128 | BML-P257-0001 | IGF 1Rtide | 1 mg |
| 6129 | BML-P258-0001 | IGF 1Rtide (biotinylated) | 1 mg |
| 6130 | BML-P259-0001 | Src substrate II | 1 mg |
| 6131 | BML-P260-0001 | Src substrate II (biotinylated) | 1 mg |
| 6132 | BML-P261-0001 | DYRK kinase substrate | 1 mg |
| 6133 | BML-P262-0001 | DYRK kinase substrate (biotinylated) | 1 mg |
| 6134 | BML-P263-0001 | CDK5 substrate | 1 mg |
| 6135 | BML-P264-0001 | CDK5 substrate (biotinylated) | 1 mg |
| 6136 | BML-P265-0001 | CDK2 substrate | 1 mg |
| 6137 | BML-P266-0001 | CDK2 substrate (biotinylated) | 1 mg |
| 6138 | BML-P267-0001 | LRRKtide | 1 mg |
| 6139 | BML-P268-0001 | LRRKtide (biotinylated) | 1 mg |
| 6140 | BML-P270-0001 | AMARA peptide substrate | 1 mg |
| 6141 | BML-P271-0500 | Histone H3 (human) (5-23) amide | 0.5 mg |
| 6142 | BML-P272-0001 | cdc2 substrate (biotinylated) | 1 mg |
| 6143 | BML-P276-0001 | Mca-Lys-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH<sub>2</sub> (fluorogenic substrate) | 1 mg |
| 6144 | BML-P277-0100 | OMNIMMP<sup>®</sup> RED fluorogenic substrate | 100 µg |
| 6145 | BML-P278-0100 | MMP-3 fluorogenic substrate | 0.1 mg |
| 6146 | BML-P300-0001 | YEEI peptide | 1 mg |
| 6147 | BML-P301-0001 | pp60<sup>c-src</sup> C-terminal phosphoregulatory peptide | 1 mg |
| 6148 | BML-P302-0200 | YEEI peptide (biotinylated) | 200 µg |
| 6149 | BML-P303-0005 | Boc-Ala-Ala-Nva-SBzl | 5 mg |
| 6150 | BML-P304-0001 | pp60<sup>c-Src</sup> C-terminal peptide | 1 mg |
| 6151 | BML-P305-0001 | SOS-1 (human) (1149-1158) | 1 mg |
| 6152 | BML-P306-0500 | Peptide A | 0.5 mg |
| 6153 | BML-P307-0001 | pp60<sup>v-src</sup> autophosphorylation site | 1 mg |
| 6154 | BML-P308-0001 | RR-src peptide | 1 mg |
| 6155 | BML-P312-0001 | pp60<sup>v-src</sup> autophosphorylation site (phosphorylated) | 1 mg |
| 6156 | BML-P314-0500 | Insulin receptor (1142-1153) | 0.5 mg |
| 6157 | BML-P315-0500 | [pTyr<sup>1146</sup>] Insulin receptor (1142-1153) | 0.5 mg |
| 6158 | BML-P316-0500 | [pTyr<sup>1150</sup>] Insulin receptor (1142-1153) | 0.5 mg |
| 6159 | BML-P317-0500 | [pTyr<sup>1151</sup>] Insulin receptor (1142-1153) | 0.5 mg |
| 6160 | BML-P318-0500 | [pTyr<sup>1146/1150/1151</sup>] Insulin receptor (1142-1153) | 0.5 mg |
| 6161 | BML-P320-0001 | IRS-1 (Tyr<sup>608</sup>) peptide | 1 mg |
| 6162 | BML-P321-0500 | [pTyr<sup>1146/1150</sup>] Insulin receptor (1142-1153) | 0.5 mg |
| 6163 | BML-P323-0001 | [pTyr<sup>992</sup>] EGF receptor (988-998) | 1 mg |
| 6164 | BML-P400-0001 | IL-1β precursor (110-123) | 1 mg |
| 6165 | BML-P402-0001 | PSTAIRE peptide | 1 mg |
| 6166 | BML-P416-0001 | Z-VAD(OMe)-FMK | 1 mg |
| 6167 | BML-P416-0005 | Z-VAD(OMe)-FMK | 5 mg |
| 6168 | BML-P420-0001 | Calcitonin (salmon) | 1 mg |
| 6169 | BML-P420-0005 | Calcitonin (salmon) | 5 mg |
| 6170 | BML-P437-0005 | Ac-VEID-pNA | 5 mg |
| 6171 | BML-P442-0005 | Ac-REQD-pNA | 5 mg |
| 6172 | BML-P448-0005 | VP-AMC | 5 mg |
| 6173 | BML-P449-0005 | DP-AMC | 5 mg |
| 6174 | BML-P450-0005 | WP-AMC | 5 mg |
| 6175 | BML-P502-0001 | [Sar<sup>9</sup>, Met(O<sub>2</sub>)<sup>11</sup>]Substance P | 1 mg |
| 6176 | BML-P503-0001 | Spantide II | 1 mg |
| 6177 | BML-P504-0001 | Spantide III | 1 mg |
| 6178 | BML-P504-0005 | Spantide III | 5 mg |
| 6179 | BML-P505-0001 | Neurokinin A | 1 mg |
| 6180 | BML-P506-0001 | [β-Ala<sup>8</sup>]Neurokinin A (4-10) | 1 mg |
| 6181 | BML-P507-0001 | MEN 10376 | 1 mg |
| 6182 | BML-P508-0001 | Neurokinin B | 1 mg |
| 6183 | BML-P509-0001 | Senktide | 1 mg |
| 6184 | BML-P510-0001 | Sendide | 1 mg |
| 6185 | BML-P600-0005 | NF-κB SN50 cell permeable inhibitory peptide | 0.5 mg |
| 6186 | BML-P601-0500 | NF-κB SN50M cell permeable control peptide | 0.5 mg |
| 6187 | BML-P603-0500 | p53 activator | 0.5 mg |
| 6188 | BML-P605-0500 | Int-H1-S6A F8 c-myc inhibitor | 0.5 mg |
| 6189 | BML-P606-0500 | Int-H1-S6A F8 control peptide | 0.5 mg |
| 6190 | BML-P607-0500 | IKK-NBD peptide | 0.5 mg |
| 6191 | BML-P608-0500 | IKK-NBD control peptide | 0.5 mg |
| 6192 | BML-P700-0005 | RGD peptide | 5 mg |
| 6193 | BML-P701-0005 | RGD control peptide | 5 mg |
| 6194 | BML-P801-0005 | Z-Leu-Arg-Gly-Gly-AMC | 5 mg |
| 6195 | BML-P802-0005 | Suc-Leu-Leu-Val-Tyr-AMC | 5 mg |
| 6196 | BML-PA1243-0025 | Pancreastatin polyclonal antibody | 25 µl |
| 6197 | BML-PA1246-0025 | Peptide histidine isoleucine polyclonal antibody | 25 µl |
| 6198 | BML-PA1246-0100 | Peptide histidine isoleucine polyclonal antibody | 100 µl |
| 6199 | BML-PA1249-0025 | Peptide histidine methionine polyclonal antibody | 25 µl |
| 6200 | BML-PA1249-0100 | Peptide histidine methionine polyclonal antibody | 100 µl |
| 6201 | BML-PA1254-0025 | Peptide tyrosine tyrosine polyclonal antibody | 25 µl |
| 6202 | BML-PA1254-0100 | Peptide tyrosine tyrosine polyclonal antibody | 100 µl |
| 6203 | BML-PD120-0010 | BRL-50481 | 10 mg |
| 6204 | BML-PD120-0050 | BRL-50481 | 50 mg |
| 6205 | BML-PD125-0005 | Cilostamide | 5 mg |
| 6206 | BML-PD125-0025 | Cilostamide | 25 mg |
| 6207 | BML-PD127-0010 | Cilostazol | 10 mg |
| 6208 | BML-PD127-0050 | Cilostazol | 50 mg |
| 6209 | BML-PD129-0010 | EHNA | 10 mg |
| 6210 | BML-PD129-0050 | EHNA | 50 mg |
| 6211 | BML-PD130-0005 | SQ 20009 | 5 mg |
| 6212 | BML-PD130-0025 | SQ 20009 | 25 mg |
| 6213 | BML-PD140-0200 | IBMX | 200 mg |
| 6214 | BML-PD140-1000 | IBMX | 1 g |
| 6215 | BML-PD141-0050 | Irsogladine . maleate | 50 mg |
| 6216 | BML-PD149-0005 | MBCQ | 5 mg |
| 6217 | BML-PD149-0025 | MBCQ | 25 mg |
| 6218 | BML-PD150-0010 | 8-Methoxymethyl-IBMX | 10 mg |
| 6219 | BML-PD155-0010 | MY-5445 | 10 mg |
| 6220 | BML-PD170-0010 | Quazinone | 10 mg |
| 6221 | BML-PD170-0050 | Quazinone | 50 mg |
| 6222 | BML-PD175-0010 | Rolipram | 10 mg |
| 6223 | BML-PD175-0050 | Rolipram | 50 mg |
| 6224 | BML-PD177-0005 | R-(-)-Rolipram | 5 mg |
| 6225 | BML-PD178-0005 | S-(+)-Rolipram | 5 mg |
| 6226 | BML-PD179-0005 | Siguazodan | 5 mg |
| 6227 | BML-PD180-0010 | Trequinsin | 10 mg |
| 6228 | BML-PD185-0020 | Vinpocetine | 20 mg |
| 6229 | BML-PD185-0100 | Vinpocetine | 100 mg |
| 6230 | BML-PD190-0100 | Zaprinast | 100 mg |
| 6231 | BML-PD195-0005 | Zardaverine | 5 mg |
| 6232 | BML-PD195-0025 | Zardaverine | 25 mg |
| 6233 | BML-PD200-0005 | BML-288 | 5 mg |
| 6234 | BML-PD200-0025 | BML-288 | 25 mg |
| 6235 | BML-PE135-0005 | Phorbol 12,13-dibutyrate | 5 mg |
| 6236 | BML-PE147-0001 | 4α-Phorbol 12,13-didecanoate | 1 mg |
| 6237 | BML-PE147-0005 | 4α-Phorbol 12,13-didecanoate | 5 mg |
| 6238 | BML-PE160-0001 | Phorbol 12-myristate 13-acetate | 1 mg |
| 6239 | BML-PE160-0005 | Phorbol 12-myristate 13-acetate | 5 mg |
| 6240 | BML-PE162-0001 | 4α-Phorbol 12-myristate 13-acetate | 1 mg |
| 6241 | BML-PE176-0100 | (+)-7-Octylindolactam V | 100 µg |
| 6242 | BML-PE180-0001 | Thapsigargin | 1 mg |
| 6243 | BML-PE180-0005 | Thapsigargin | 5 mg |
| 6244 | BML-PE182-0001 | 12-Deoxyphorbol 13-phenylacetate 20-acetate | 1 mg |
| 6245 | BML-PE186-0001 | Ingenol 3,20-dibenzoate | 1 mg |
| 6246 | BML-PE187-0001 | 12-Deoxyphorbol 13-acetate | 1 mg |
| 6247 | BML-PE190-0010 | Farnesyl thiotriazole | 10 mg |
| 6248 | BML-PE190-0050 | Farnesyl thiotriazole | 50 mg |
| 6249 | BML-PG001-0010 | Prostaglandin A<sub>1</sub> | 10 mg |
| 6250 | BML-PG002-0010 | Prostaglandin A<sub>2</sub> | 10 mg |
| 6251 | BML-PG003-0001 | Prostaglandin B<sub>1</sub> | 1 mg |
| 6252 | BML-PG003-0010 | Prostaglandin B<sub>1</sub> | 10 mg |
| 6253 | BML-PG004-0010 | Prostaglandin B<sub>2</sub> | 10 mg |
| 6254 | BML-PG005-0001 | Prostaglandin D<sub>2</sub> | 1 mg |
| 6255 | BML-PG005-0010 | Prostaglandin D<sub>2</sub> | 10 mg |
| 6256 | BML-PG006-0010 | Prostaglandin E<sub>1</sub> | 10 mg |
| 6257 | BML-PG007-0001 | Prostaglandin E<sub>2</sub> | 1 mg |
| 6258 | BML-PG007-0010 | Prostaglandin E<sub>2</sub> | 10 mg |
| 6259 | BML-PG008-0002 | Prostaglandin F<sub>2α</sub> | 2 mg |
| 6260 | BML-PG008-0010 | Prostaglandin F<sub>2α</sub> | 10 mg |
| 6261 | BML-PG009-0001 | Prostaglandin F<sub>2α</sub> . tromethamine | 1 mg |
| 6262 | BML-PG009-0010 | Prostaglandin F<sub>2α</sub> . tromethamine | 10 mg |
| 6263 | BML-PG010-0001 | Prostaglandin F<sub>1α</sub> | 1 mg |
| 6264 | BML-PG011-0001 | Prostaglandin I<sub>2</sub> sodium | 1 mg |
| 6265 | BML-PG011-0010 | Prostaglandin I<sub>2</sub> sodium | 10 mg |
| 6266 | BML-PG017-0001 | 6-Ketoprostaglandin F<sub>1α</sub> | 1 mg |
| 6267 | BML-PG023-0001 | U-46619 | 1 mg |
| 6268 | BML-PG023-0010 | U-46619 | 10 mg |
| 6269 | BML-PG030-0001 | 9β,11α-Prostaglandin F<sub>2</sub> | 1 mg |
| 6270 | BML-PG031-0001 | 9α,11β-Prostaglandin F<sub>2</sub> | 1 mg |
| 6271 | BML-PG036-0001 | (±)13-Azaprostanoic acid | 1 mg |
| 6272 | BML-PG036-0010 | (±)13-Azaprostanoic acid | 10 mg |
| 6273 | BML-PG038-0050 | 19(R)-Hydroxyprostaglandin E<sub>2</sub> | 50 µg |
| 6274 | BML-PG040-0050 | 2,3-Dinor-6-keto-prostaglandin F<sub>1α</sub>-20,20,20-d<sub>3</sub> | 50 µg |
| 6275 | BML-PG042-0001 | 17-Phenyl-trinor-prostaglandin E<sub>2</sub> | 1 mg |
| 6276 | BML-PG048-0001 | 13,14-Dihydro-prostaglandin E<sub>1</sub> | 1 mg |
| 6277 | BML-PG048-0010 | 13,14-Dihydro-prostaglandin E<sub>1</sub> | 10 mg |
| 6278 | BML-PG050-0001 | 15-Deoxy-Δ<sup>12,14</sup>-prostaglandin J<sub>2</sub> | 1 mg |
| 6279 | BML-PG050-0005 | 15-Deoxy-Δ<sup>12,14</sup>-prostaglandin J<sub>2</sub> | 5 mg |
| 6280 | BML-PG051-0010 | Misoprostol | 10 mg |
| 6281 | BML-PG051-0100 | Misoprostol | 100 mg |
| 6282 | BML-PG052-0001 | Misoprostol, free acid | 1 mg |
| 6283 | BML-PG052-0010 | Misoprostol, free acid | 10 mg |
| 6284 | BML-PH002-0050 | Prostaglandin H<sub>2</sub> | 50 µg |
| 6285 | BML-PH100-0010 | L-α-Phosphatidylinositol | 10 mg |
| 6286 | BML-PH106-0100 | L-α-Phosphatidylinositol-3,4-P2 | 100 µg |
| 6287 | BML-PH107-0100 | L-α-Phosphatidylinositol-3,4,5-P3 . 7Na | 100 µg |
| 6288 | BML-PI100-0005 | N-Acetyl-Leu-Leu-Methional | 5 mg |
| 6289 | BML-PI100-0025 | N-Acetyl-Leu-Leu-Methional | 25 mg |
| 6290 | BML-PI101-0010 | Calpeptin | 10 mg |
| 6291 | BML-PI101-0050 | Calpeptin | 50 mg |
| 6292 | BML-PI102-0005 | MG-132 | 5 mg |
| 6293 | BML-PI102-0025 | MG-132 | 25 mg |
| 6294 | BML-PI103-0005 | Elastatinal | 5 mg |
| 6295 | BML-PI103-0025 | Elastatinal | 25 mg |
| 6296 | BML-PI104-0200 | Lactacystin | 200 µg |
| 6297 | BML-PI104-1000 | Lactacystin | 1 mg |
| 6298 | BML-PI106-0001 | E-64-C | 1 mg |
| 6299 | BML-PI106-0005 | E-64-C | 5 mg |
| 6300 | BML-PI107-0001 | E-64-D | 1 mg |
| 6301 | BML-PI107-0005 | E-64-D | 5 mg |
| 6302 | BML-PI108-0100 | <em>clasto</em>-Lactacystin β-Lactone | 100 µg |
| 6303 | BML-PI109-0100 | Z-Leu-Leu-Leu-B(OH)<sub>2</sub> | 100 µg |
| 6304 | BML-PI110-0010 | 3,4 Dichloroisocoumarin | 10 mg |
| 6305 | BML-PI111-0005 | Phosphoramidon | 5 mg |
| 6306 | BML-PI111-0025 | Phosphoramidon | 25 mg |
| 6307 | BML-PI112-0005 | Z-prolyl-prolinal | 5 mg |
| 6308 | BML-PI112-0025 | Z-prolyl-prolinal | 25 mg |
| 6309 | BML-PI113-0005 | Thiorphan | 5 mg |
| 6310 | BML-PI113-0025 | Thiorphan | 25 mg |
| 6311 | BML-PI115-0005 | NNGH | 5 mg |
| 6312 | BML-PI115-0025 | NNGH | 25 mg |
| 6313 | BML-PI116-0005 | Z-Leu-Leu-CHO | 5 mg |
| 6314 | BML-PI116-0025 | Z-Leu-Leu-CHO | 25 mg |
| 6315 | BML-PI117-0005 | PPACK | 5 mg |
| 6316 | BML-PI117-0025 | PPACK | 25 mg |
| 6317 | BML-PI121-0200 | TLCK | 200 mg |
| 6318 | BML-PI122-0001 | TPCK | 1 g |
| 6319 | BML-PI123-0005 | AAF-CMK | 5 mg |
| 6320 | BML-PI123-0025 | AAF-CMK | 25 mg |
| 6321 | BML-PI124-0005 | Z-AAF-CMK | 5 mg |
| 6322 | BML-PI125-0001 | NapSul-Ile-Trp-CHO | 1 mg |
| 6323 | BML-PI125-0005 | NapSul-Ile-Trp-CHO | 5 mg |
| 6324 | BML-PI126-0001 | CA-074 Me | 1 mg |
| 6325 | BML-PI127-0100 | Epoxomicin | 100 µg |
| 6326 | BML-PI128-0005 | Boc-Gly-Val-Val-CHO | 5 mg |
| 6327 | BML-PI128-0025 | Boc-Gly-Val-Val-CHO | 25 mg |
| 6328 | BML-PI129-0002 | Gliotoxin | 2 mg |
| 6329 | BML-PI129-0010 | Gliotoxin | 10 mg |
| 6330 | BML-PI130-0010 | MDL-28170 | 10 mg |
| 6331 | BML-PI130-0050 | MDL-28170 | 50 mg |
| 6332 | BML-PI133-0001 | TAPI-0 | 1 mg |
| 6333 | BML-PI134-0001 | TAPI-1 | 1 mg |
| 6334 | BML-PI135-0001 | TAPI-2 | 1 mg |
| 6335 | BML-PI136-0001 | CTT | 1 mg |
| 6336 | BML-PI136-0005 | CTT | 5 mg |
| 6337 | BML-PI137-0001 | STT Negative Control for Gelatinase | 1 mg |
| 6338 | BML-PI137-0005 | STT Negative Control for Gelatinase | 5 mg |
| 6339 | BML-PI138-0001 | Z-Phe-Ala-FMK | 1 mg |
| 6340 | BML-PI138-0005 | Z-Phe-Ala-FMK | 5 mg |
| 6341 | BML-PI139-0100 | Z-Pro-Leu-Gly-NHOH | 100 mg |
| 6342 | BML-PI140-0005 | BML-244 | 5 mg |
| 6343 | BML-PI140-0025 | BML-244 | 25 mg |
| 6344 | BML-PI142-0010 | P32/98 | 10 mg |
| 6345 | BML-PI142-0050 | P32/98 | 50 mg |
| 6346 | BML-PI143-0010 | Nafamostat . mesylate | 10 mg |
| 6347 | BML-PI143-0050 | Nafamostat . mesylate | 50 mg |
| 6348 | BML-PI144-0010 | Gabexate . mesylate | 10 mg |
| 6349 | BML-PI144-0050 | Gabexate . mesylate | 50 mg |
| 6350 | BML-PI145-0001 | Apstatin | 1 mg |
| 6351 | BML-PI146-0010 | Argatroban | 10 mg |
| 6352 | BML-PI146-0050 | Argatroban | 50 mg |
| 6353 | BML-PI147-0005 | PKSI-527 | 5 mg |
| 6354 | BML-PI147-0025 | PKSI-527 | 25 mg |
| 6355 | BML-PI153-0050 | Cilastatin Sodium | 50 mg |
| 6356 | BML-PI155-0001 | PF-356231 | 1 mg |
| 6357 | BML-PI155-0005 | PF-356231 | 5 mg |
| 6358 | BML-PI156-0005 | H-Glu-Gly-Arg-CMK | 5 mg |
| 6359 | BML-PI157-0010 | Sivelestat sodium | 10 mg |
| 6360 | BML-PI157-0050 | Sivelestat sodium | 50 mg |
| 6361 | BML-PL012-0100 | 12-Lipoxygenase (pig) | 100 U |
| 6362 | BML-PP9350-0100 | Blocking peptide for Valosin-containing protein pAb (Prod. No. BML-PW9335) | 100 µg |
| 6363 | BML-PP9365-0100 | Blocking peptide for Parkin (human) pAb (Prod. No. BML-PW9365) | 100 µg |
| 6364 | BML-PP9470-0100 | Blocking peptide for SUMO-1 (human) (NT) pAb (Prod. No. BML-PW8330) | 100 µg |
| 6365 | BML-PP9475-0100 | Blocking peptide for SUMO-1 (human) (CT) pAb (Prod. No. BML-PW9460) | 100 µg |
| 6366 | BML-PP9480-0100 | Blocking peptide for SUMO-2/3 (human) (NT) pAb (Prod. No. BML-PW9465) | 100 µg |
| 6367 | BML-PP9543-0100 | N-acetyl-Peptide YY[3-36]amide (pig/rat) | 100 µg |
| 6368 | BML-PP9580-0100 | Blocking peptide for FAT10 pAb (Prod. No. BML-PW9585) | 100 µg |
| 6369 | BML-PP9590-0100 | Blocking peptide for ISG15 (human) pAb (Prod. No. BML-PW9575) | 100 µg |
| 6370 | BML-PP9600-0100 | Blocking peptide for Urm1 (human) pAb (Prod. No. BML-PW9595) | 100 µg |
| 6371 | BML-PP9620-0100 | Blocking peptide for Fub1 (human) pAb (Prod. No. BML-PW9615) | 100 µg |
| 6372 | BML-PR100-0050 | Cypermethrin | 50 mg |
| 6373 | BML-PR101-0010 | Deltamethrin | 10 mg |
| 6374 | BML-PR101-0050 | Deltamethrin | 50 mg |
| 6375 | BML-PR103-0050 | Permethrin | 50 mg |
| 6376 | BML-PR104-0500 | Calcineurin inhibitory peptide | 0.5 mg |
| 6377 | BML-PR106-0010 | Cantharidic acid | 10 mg |
| 6378 | BML-PR106-0050 | Cantharidic acid | 50 mg |
| 6379 | BML-PR107-0100 | Endothall | 100 mg |
| 6380 | BML-PR110-0001 | RWJ-60475 (AM)<sub>3</sub> | 1 mg |
| 6381 | BML-PR112-0200 | RK-682 | 200 µg |
| 6382 | BML-PR112-1000 | RK-682 | 1 mg |
| 6383 | BML-PR113-0010 | Tyrphostin 8 | 10 mg |
| 6384 | BML-PR113-0050 | Tyrphostin 8 | 50 mg |
| 6385 | BML-PR114-0001 | CinnGEL | 1 mg |
| 6386 | BML-PR115-0001 | CinnGEL 2-methylester | 1 mg |
| 6387 | BML-PR117-0010 | Artesunate | 10 mg |
| 6388 | BML-PR119-0010 | BML-260 | 10 mg |
| 6389 | BML-PR121-0010 | BML-267 | 10 mg |
| 6390 | BML-PR121-0050 | BML-267 | 50 mg |
| 6391 | BML-PR131-0050 | BMOV | 50 mg |
| 6392 | BML-PW0150-0025 | Mono- and polyubiquitinylated conjugates monoclonal antibody (FK2) (HRP conjugate) | 25 µg |
| 6393 | BML-PW0150-0100 | Mono- and polyubiquitinylated conjugates monoclonal antibody (FK2) (HRP conjugate) | 100 µg |
| 6394 | BML-PW0190-0025 | CUL1 (<i>Arabidopsis thaliana</i>) polyclonal antibody | 25 µl |
| 6395 | BML-PW0325-0025 | Sp100 (human) polyclonal antibody | 25 µl |
| 6396 | BML-PW0325-0100 | Sp100 (human) polyclonal antibody | 100 µl |
| 6397 | BML-PW0330-0025 | Sp100 (SUMO modified) (human) polyclonal antibody | 25 µl |
| 6398 | BML-PW0330-0100 | Sp100 (SUMO modified) (human) polyclonal antibody | 100 µl |
| 6399 | BML-PW0365-0025 | SENP5 (human) polyclonal antibody | 25 µl |
| 6400 | BML-PW0365-0100 | SENP5 (human) polyclonal antibody | 100 µl |
| 6401 | BML-PW0370-0025 | SENP6 (human) polyclonal antibody | 25 µl |
| 6402 | BML-PW0370-0100 | SENP6 (human) polyclonal antibody | 100 µl |
| 6403 | BML-PW0430-0025 | PBA1 (<i>Arabidopsis thaliana</i>) polyclonal antibody | 25 µl |
| 6404 | BML-PW0430-0100 | PBA1 (<i>Arabidopsis thaliana</i>) polyclonal antibody | 100 µl |
| 6405 | BML-PW0435-0025 | PBF1 (<i>Arabidopsis thaliana</i>) polyclonal antibody | 25 µl |
| 6406 | BML-PW0435-0100 | PBF1 (<i>Arabidopsis thaliana</i>) polyclonal antibody | 100 µl |
| 6407 | BML-PW0440-0025 | Proteasome 19S Rpn12/S14 subunit polyclonal antibody | 25 µl |
| 6408 | BML-PW0445-0025 | Proteasome 19S Rpt2/S4 subunit polyclonal antibody | 25 µl |
| 6409 | BML-PW0445-0100 | Proteasome 19S Rpt2/S4 subunit polyclonal antibody | 100 µl |
| 6410 | BML-PW0450-0025 | Proteasome 19S Rpn5 subunit polyclonal antibody | 25 µl |
| 6411 | BML-PW0455-0025 | DDA1 polyclonal antibody | 25 µl |
| 6412 | BML-PW0455-0100 | DDA1 polyclonal antibody | 100 µl |
| 6413 | BML-PW0460-0025 | DDB1 polyclonal antibody | 25 µl |
| 6414 | BML-PW0465-0025 | AtRbx1 (<i>Arabidopsis thaliana</i>) polyclonal antibody | 25 µl |
| 6415 | BML-PW0470-0025 | AtCul3 (<i>Arabidopsis thaliana</i>) polyclonal antibody | 25 µl |
| 6416 | BML-PW0485-0025 | PAC2 (human) monoclonal antibody (EX-6) | 25 µg |
| 6417 | BML-PW0485-0100 | PAC2 (human) monoclonal antibody (EX-6) | 100 µg |
| 6418 | BML-PW0490-0025 | PAC3 (human) monoclonal antibody (EX-7) | 25 µg |
| 6419 | BML-PW0490-0100 | PAC3 (human) monoclonal antibody (EX-7) | 100 µg |
| 6420 | BML-PW0505A-0025 | SUMO-1 (human) polyclonal antibody | 25 µg |
| 6421 | BML-PW0505A-0100 | SUMO-1 (human) polyclonal antibody | 100 µg |
| 6422 | BML-PW0510A-0025 | SUMO-2 (human) polyclonal antibody | 25 µg |
| 6423 | BML-PW0510A-0100 | SUMO-2 (human) polyclonal antibody | 100 µg |
| 6424 | BML-PW0525-0025 | UBA6 (human) polyclonal antibody | 25 µl |
| 6425 | BML-PW0525-0100 | UBA6 (human) polyclonal antibody | 100 µl |
| 6426 | BML-PW0530-0025 | Proteasome 19S Rpt2/S4 subunit (human) polyclonal antibody | 25 µl |
| 6427 | BML-PW0530-0100 | Proteasome 19S Rpt2/S4 subunit (human) polyclonal antibody | 100 µl |
| 6428 | BML-PW0535-0025 | E6AP (human) monoclonal antibody (EX-8) | 25 µg |
| 6429 | BML-PW0535-0100 | E6AP (human) monoclonal antibody (EX-8) | 100 µg |
| 6430 | BML-PW0540-0025 | USP-7 (human) polyclonal antibody | 25 µl |
| 6431 | BML-PW0540-0100 | USP-7 (human) polyclonal antibody | 100 µl |
| 6432 | BML-PW0570-0025 | Blm10 (Saccharomyces cerevisiae) polyclonal antibody | 25 µl |
| 6433 | BML-PW0575-0001 | Proteasome ELISA kit | 96 wells |
| 6434 | BML-PW0580-0025 | Ubiquitin monoclonal antibody (EX-9) | 25 µl |
| 6435 | BML-PW0580-0100 | Ubiquitin monoclonal antibody (EX-9) | 100 µl |
| 6436 | BML-PW0585-0025 | USP21 (human) polyclonal antibody | 25 µl |
| 6437 | BML-PW0585-0100 | USP21 (human) polyclonal antibody | 100 µl |
| 6438 | BML-PW0595A-0025 | Huntingtin polyclonal antibody | 25 µg |
| 6439 | BML-PW0595A-0100 | Huntingtin polyclonal antibody | 100 µg |
| 6440 | BML-PW0600-0025 | Polyubiquitin (K<sup>63</sup>-linkage-specific) monoclonal antibody (HWA4C4) | 25 µl |
| 6441 | BML-PW0600-0100 | Polyubiquitin (K<sup>63</sup>-linkage-specific) monoclonal antibody (HWA4C4) | 100 µl |
| 6442 | BML-PW0605-0025 | Polyubiquitin (K<sup>63</sup>-linkage-specific) monoclonal antibody (HWA4C4) (HRP conjugate) | 25 µg |
| 6443 | BML-PW0605-0100 | Polyubiquitin (K<sup>63</sup>-linkage-specific) monoclonal antibody (HWA4C4) (HRP conjugate) | 100 µg |
| 6444 | BML-PW0655-0025 | AMSH (human) polyclonal antibody | 25 µl |
| 6445 | BML-PW0655-0100 | AMSH (human) polyclonal antibody | 100 µl |
| 6446 | BML-PW0660-0025 | MYSM1 (human) polyclonal antibody | 25 µl |
| 6447 | BML-PW0660-0100 | MYSM1 (human) polyclonal antibody | 100 µl |
| 6448 | BML-PW0755-0025 | Mono- and polyubiquitinylated conjugates monoclonal antibody (FK2) (biotin conjugate) | 25 µl |
| 6449 | BML-PW0755-0100 | Mono- and polyubiquitinylated conjugates monoclonal antibody (FK2) (biotin conjugate) | 100 µl |
| 6450 | BML-PW0760-0025 | CYLD (human) polyclonal antibody | 25 µl |
| 6451 | BML-PW0760-0100 | CYLD (human) polyclonal antibody | 100 µl |
| 6452 | BML-PW0770-0025 | Use1 (human) polyclonal antibody | 25 µl |
| 6453 | BML-PW0770-0100 | Use1 (human) polyclonal antibody | 100 µl |
| 6454 | BML-PW0920-0025 | Herc5 (human) polyclonal antibody | 25 µl |
| 6455 | BML-PW0920-0100 | Herc5 (human) polyclonal antibody | 100 µl |
| 6456 | BML-PW0930-0100 | Ubiquitin monoclonal antibody (P4D1) | 100 µg |
| 6457 | BML-PW0930-1000 | Ubiquitin monoclonal antibody (P4D1) | 1 mg |
| 6458 | BML-PW0935-0025 | Ubiquitin monoclonal antibody (P4D1) (HRP conjugate) | 25 µl |
| 6459 | BML-PW0935-0100 | Ubiquitin monoclonal antibody (P4D1) (HRP conjugate) | 100 µl |
| 6460 | BML-PW0945-0025 | USP18 (human) polyclonal antibody | 25 µl |
| 6461 | BML-PW0945-0100 | USP18 (human) polyclonal antibody | 100 µl |
| 6462 | BML-PW0950-0025 | Huwe1 (mouse) polyclonal antibody | 25 µl |
| 6463 | BML-PW0950-0100 | Huwe1 (mouse) polyclonal antibody | 100 µl |
| 6464 | BML-PW0975-0025 | USP30 (human) polyclonal antibody | 25 µl |
| 6465 | BML-PW0975-0100 | USP30 (human) polyclonal antibody | 100 µl |
| 6466 | BML-PW1020-0025 | Proteasome 20S β5t subunit (human) monoclonal antibody (b8-17) | 25 µl |
| 6467 | BML-PW1020-0100 | Proteasome 20S β5t subunit (human) monoclonal antibody (b8-17) | 100 µl |
| 6468 | BML-PW1025-0025 | USP19 polyclonal antibody | 25 µl |
| 6469 | BML-PW1025-0100 | USP19 polyclonal antibody | 100 µl |
| 6470 | BML-PW1045-0025 | S5a (human) polyclonal antibody | 25 µl |
| 6471 | BML-PW1045-0100 | S5a (human) polyclonal antibody | 100 µl |
| 6472 | BML-PW1075A-0001 | Proteasome purification kit | 10 tests |
| 6473 | BML-PW1085-0025 | p53 (human) monoclonal antibody (PAb1801) | 25 µg |
| 6474 | BML-PW1095-0025 | p53 (human) monoclonal antibody (DO-7) | 25 µg |
| 6475 | BML-PW1100-0025 | p53 (human) monoclonal antibody (EX-2) | 25 µg |
| 6476 | BML-PW1105-0025 | p53 monoclonal antibody (EX-1) | 25 µg |
| 6477 | BML-PW1110-0025 | p53 (human) monoclonal antibody (EX-4) | 25 µg |
| 6478 | BML-PW1115-0025 | p53 (human) monoclonal antibody (EX-3) | 25 µg |
| 6479 | BML-PW1205-0025 | LC3 monoclonal antibody (2G6) (fluorescein labeled) | 25 µl |
| 6480 | BML-PW1210-0025 | Mono- and polyubiquitinylated conjugates monoclonal antibody (FK2) (fluorescein labeled) | 25 µl |
| 6481 | BML-PW1335-0025 | Mono- and polyubiquitinylated conjugates monoclonal antibody (FK2) (ATTO 488 conjugate) | 25 µl |
| 6482 | BML-PW8100-0025 | Proteasome 20S α6 subunit monoclonal antibody (MCP20) | 25 µl |
| 6483 | BML-PW8100-0100 | Proteasome 20S α6 subunit monoclonal antibody (MCP20) | 100 µl |
| 6484 | BML-PW8105-0025 | Proteasome 20S α2 subunit monoclonal antibody (MCP21) | 25 µl |
| 6485 | BML-PW8105-0100 | Proteasome 20S α2 subunit monoclonal antibody (MCP21) | 100 µl |
| 6486 | BML-PW8110-0025 | Proteasome 20S α7 subunit monoclonal antibody (MCP72) | 25 µl |
| 6487 | BML-PW8110-0100 | Proteasome 20S α7 subunit monoclonal antibody (MCP72) | 100 µl |
| 6488 | BML-PW8115-0025 | Proteasome 20S α3 subunit monoclonal antibody (MCP257) | 25 µl |
| 6489 | BML-PW8115-0100 | Proteasome 20S α3 subunit monoclonal antibody (MCP257) | 100 µl |
| 6490 | BML-PW8120-0025 | Proteasome 20S α4 subunit (human) monoclonal antibody (MCP34) | 25 µl |
| 6491 | BML-PW8120-0100 | Proteasome 20S α4 subunit (human) monoclonal antibody (MCP34) | 100 µl |
| 6492 | BML-PW8125-0025 | Proteasome 20S α5 subunit monoclonal antibody (MCP196) | 25 µl |
| 6493 | BML-PW8125-0100 | Proteasome 20S α5 subunit monoclonal antibody (MCP196) | 100 µl |
| 6494 | BML-PW8130-0025 | Proteasome 20S β3 subunit monoclonal antibody (MCP102) | 25 µl |
| 6495 | BML-PW8130-0100 | Proteasome 20S β3 subunit monoclonal antibody (MCP102) | 100 µl |
| 6496 | BML-PW8135-0025 | Proteasome 20S β7 subunit monoclonal antibody (MCP205) | 25 µl |
| 6497 | BML-PW8135-0100 | Proteasome 20S β7 subunit monoclonal antibody (MCP205) | 100 µl |
| 6498 | BML-PW8140-0025 | Proteasome 20S β1 subunit monoclonal antibody (MCP421) | 25 µl |
| 6499 | BML-PW8140-0100 | Proteasome 20S β1 subunit monoclonal antibody (MCP421) | 100 µl |
| 6500 | BML-PW8145-0025 | Proteasome 20S β2 subunit monoclonal antibody (MCP168) | 25 µl |
| 6501 | BML-PW8145-0100 | Proteasome 20S β2 subunit monoclonal antibody (MCP168) | 100 µl |
| 6502 | BML-PW8150-0025 | Proteasome 20S β2i subunit polyclonal antibody | 25 µl |
| 6503 | BML-PW8150-0100 | Proteasome 20S β2i subunit polyclonal antibody | 100 µl |
| 6504 | BML-PW8155-0025 | Proteasome 20S core subunits polyclonal antibody | 25 µl |
| 6505 | BML-PW8155-0100 | Proteasome 20S core subunits polyclonal antibody | 100 µl |
| 6506 | BML-PW8165-0025 | Proteasome 19S Rpt1/S7 subunit polyclonal antibody | 25 µl |
| 6507 | BML-PW8165-0100 | Proteasome 19S Rpt1/S7 subunit polyclonal antibody | 100 µl |
| 6508 | BML-PW8180-0025 | Proteasome 19S Rpn8/S12 subunit (human) polyclonal antibody | 25 µl |
| 6509 | BML-PW8185-0025 | Proteasome activator 11S α subunit polyclonal antibody | 25 µl |
| 6510 | BML-PW8185-0100 | Proteasome activator 11S α subunit polyclonal antibody | 100 µl |
| 6511 | BML-PW8190-0025 | Proteasome activator 11S γ subunit polyclonal antibody | 25 µl |
| 6512 | BML-PW8190-0100 | Proteasome activator 11S γ subunit polyclonal antibody | 100 µl |
| 6513 | BML-PW8195-0025 | Proteasome 20S α1, 2, 3, 5, 6 & 7 subunits monoclonal antibody (MCP231) | 25 µl |
| 6514 | BML-PW8195-0100 | Proteasome 20S α1, 2, 3, 5, 6 & 7 subunits monoclonal antibody (MCP231) | 100 µl |
| 6515 | BML-PW8205-0025 | Proteasome 20S β1i subunit polyclonal antibody | 25 µl |
| 6516 | BML-PW8205-0100 | Proteasome 20S β1i subunit polyclonal antibody | 100 µl |
| 6517 | BML-PW8210-0025 | Proteasome 20S β2i subunit polyclonal antibody | 25 µl |
| 6518 | BML-PW8210-0100 | Proteasome 20S β2i subunit polyclonal antibody | 100 µl |
| 6519 | BML-PW8215-0025 | Proteasome 19S Rpt6/S8 subunit polyclonal antibody | 25 µl |
| 6520 | BML-PW8215-0100 | Proteasome 19S Rpt6/S8 subunit polyclonal antibody | 100 µl |
| 6521 | BML-PW8220-0100 | Proteasome 19S Rpt4/S10b subunit polyclonal antibody | 100 µl |
| 6522 | BML-PW8225-0025 | Proteasome 19S Rpn7/S10a subunit polyclonal antibody | 25 µl |
| 6523 | BML-PW8225-0100 | Proteasome 19S Rpn7/S10a subunit polyclonal antibody | 100 µl |
| 6524 | BML-PW8230-0025 | COP9 signalosome Csn2 subunit polyclonal antibody | 25 µl |
| 6525 | BML-PW8230-0100 | COP9 signalosome Csn2 subunit polyclonal antibody | 100 µl |
| 6526 | BML-PW8235-0025 | COP9 signalosome Csn3 subunit polyclonal antibody | 25 µl |
| 6527 | BML-PW8235-0100 | COP9 signalosome Csn3 subunit polyclonal antibody | 100 µl |
| 6528 | BML-PW8240-0025 | Proteasome activator 11S β subunit polyclonal antibody | 25 µl |
| 6529 | BML-PW8240-0100 | Proteasome activator 11S β subunit polyclonal antibody | 100 µl |
| 6530 | BML-PW8245-0025 | Proteasome 19S Rpt5/S6a subunit polyclonal antibody | 25 µl |
| 6531 | BML-PW8245-0100 | Proteasome 19S Rpt5/S6a subunit polyclonal antibody | 100 µl |
| 6532 | BML-PW8250-0025 | Proteasome 19S Rpt3/S6b subunit polyclonal antibody | 25 µl |
| 6533 | BML-PW8250-0100 | Proteasome 19S Rpt3/S6b subunit polyclonal antibody | 100 µl |
| 6534 | BML-PW8255-0025 | Proteasome 19S Rpt1/S7 subunit (yeast) polyclonal antibody | 25 µl |
| 6535 | BML-PW8255-0100 | Proteasome 19S Rpt1/S7 subunit (yeast) polyclonal antibody | 100 µl |
| 6536 | BML-PW8260-0025 | Proteasome 19S Rpt2/S4 subunit (yeast) polyclonal antibody | 25 µl |
| 6537 | BML-PW8260-0100 | Proteasome 19S Rpt2/S4 subunit (yeast) polyclonal antibody | 100 µl |
| 6538 | BML-PW8265-0100 | Proteasome 20S α subunit (human) monoclonal antibody (HP810) | 100 µg |
| 6539 | BML-PW8270-0100 | Proteasome 20S α5 subunit (human) monoclonal antibody (HP903) | 100 µg |
| 6540 | BML-PW8275-0100 | Proteasome 20S α subunit (human) monoclonal antibody (HP103) | 100 µg |
| 6541 | BML-PW8280-0100 | Proteasome 20S α subunit (human) monoclonal antibody (HP305) | 100 µg |
| 6542 | BML-PW8285-0025 | COP9 signalosome Csn1 subunit polyclonal antibody | 25 µl |
| 6543 | BML-PW8285-0100 | COP9 signalosome Csn1 subunit polyclonal antibody | 100 µl |
| 6544 | BML-PW8290-0025 | COP9 signalosome Csn8 subunit polyclonal antibody | 25 µl |
| 6545 | BML-PW8290-0100 | COP9 signalosome Csn8 subunit polyclonal antibody | 100 µl |
| 6546 | BML-PW8295-0025 | COP9 signalosome Csn6 subunit (human) polyclonal antibody | 25 µl |
| 6547 | BML-PW8295-0100 | COP9 signalosome Csn6 subunit (human) polyclonal antibody | 100 µl |
| 6548 | BML-PW8300-0025 | COP9 signalosome Csn7 subunit (human) polyclonal antibody | 25 µl |
| 6549 | BML-PW8300-0100 | COP9 signalosome Csn7 subunit (human) polyclonal antibody | 100 µl |
| 6550 | BML-PW8305-0025 | Proteasome 19S Rpt2/S4 subunit polyclonal antibody | 25 µl |
| 6551 | BML-PW8305-0100 | Proteasome 19S Rpt2/S4 subunit polyclonal antibody | 100 µl |
| 6552 | BML-PW8310-0025 | Proteasome 19S Rpt5/S6a subunit (human) polyclonal antibody | 25 µl |
| 6553 | BML-PW8310-0100 | Proteasome 19S Rpt5/S6a subunit (human) polyclonal antibody | 100 µl |
| 6554 | BML-PW8315-0025 | Proteasome 19S Rpt1/S7 subunit (human) polyclonal antibody | 25 µl |
| 6555 | BML-PW8315-0100 | Proteasome 19S Rpt1/S7 subunit (human) polyclonal antibody | 100 µl |
| 6556 | BML-PW8320-0025 | Proteasome 19S ATPase subunit Rpt6/S8 (human) polyclonal antibody | 25 µl |
| 6557 | BML-PW8320-0100 | Proteasome 19S ATPase subunit Rpt6/S8 (human) polyclonal antibody | 100 µl |
| 6558 | BML-PW8325-0025 | Gankyrin (human) polyclonal antibody | 25 µl |
| 6559 | BML-PW8330-0025 | SUMO-1 (human) (NT) polyclonal antibody | 25 µl |
| 6560 | BML-PW8330-0100 | SUMO-1 (human) (NT) polyclonal antibody | 100 µl |
| 6561 | BML-PW8335-0500 | Proteasome 20S α2 subunit monoclonal antibody (MCP21) (agarose immobilized) | 0.5 ml |
| 6562 | BML-PW8345-0025 | Proteasome 20S β1i subunit (human) polyclonal antibody | 25 µl |
| 6563 | BML-PW8345-0100 | Proteasome 20S β1i subunit (human) polyclonal antibody | 100 µl |
| 6564 | BML-PW8350-0025 | Proteasome 20S β2i subunit (human) polyclonal antibody | 25 µl |
| 6565 | BML-PW8350-0100 | Proteasome 20S β2i subunit (human) polyclonal antibody | 100 µl |
| 6566 | BML-PW8355-0025 | Proteasome 20S β5i subunit (human) polyclonal antibody | 25 µl |
| 6567 | BML-PW8355-0100 | Proteasome 20S β5i subunit (human) polyclonal antibody | 100 µl |
| 6568 | BML-PW8360-0025 | COP9 signalosome Csn4 subunit polyclonal antibody | 25 µl |
| 6569 | BML-PW8360-0100 | COP9 signalosome Csn4 subunit polyclonal antibody | 100 µl |
| 6570 | BML-PW8365-0025 | COP9 signalosome Csn5 subunit polyclonal antibody | 25 µl |
| 6571 | BML-PW8365-0100 | COP9 signalosome Csn5 subunit polyclonal antibody | 100 µl |
| 6572 | BML-PW8375-0025 | Proteasome 19S polyclonal antibody | 25 µl |
| 6573 | BML-PW8375-0100 | Proteasome 19S polyclonal antibody | 100 µl |
| 6574 | BML-PW8390-0025 | Ubiquitin activating enzyme polyclonal antibody | 25 µl |
| 6575 | BML-PW8390-0100 | Ubiquitin activating enzyme polyclonal antibody | 100 µl |
| 6576 | BML-PW8395-0025 | Ubiquitin activating enzyme (CT) polyclonal antibody | 25 µl |
| 6577 | BML-PW8720-0050 | Proteasome 20S (human), (purified) | 50 µg |
| 6578 | BML-PW8765-0025 | Proteasome 19S Rpt3/S6b subunit monoclonal antibody (TBP7-27) | 25 µl |
| 6579 | BML-PW8765-0100 | Proteasome 19S Rpt3/S6b subunit monoclonal antibody (TBP7-27) | 100 µl |
| 6580 | BML-PW8770-0025 | Proteasome 19S Rpt5/S6a subunit monoclonal antibody (TBP1-19) | 25 µl |
| 6581 | BML-PW8770-0100 | Proteasome 19S Rpt5/S6a subunit monoclonal antibody (TBP1-19) | 100 µl |
| 6582 | BML-PW8785-0025 | RanGAP1 (human) polyclonal antibody | 25 µl |
| 6583 | BML-PW8785-0100 | RanGAP1 (human) polyclonal antibody | 100 µl |
| 6584 | BML-PW8805-0500 | Polyubiquitinylated conjugates monoclonal antibody (FK1) | 500 µg |
| 6585 | BML-PW8815-0025 | Proteasome 19S Rpn12/S14 subunit (human) polyclonal antibody | 25 µl |
| 6586 | BML-PW8815-0100 | Proteasome 19S Rpn12/S14 subunit (human) polyclonal antibody | 100 µl |
| 6587 | BML-PW8825-0025 | Proteasome 19S Rpt1/S7 subunit monoclonal antibody (MSS1-104) | 25 µl |
| 6588 | BML-PW8825-0100 | Proteasome 19S Rpt1/S7 subunit monoclonal antibody (MSS1-104) | 100 µl |
| 6589 | BML-PW8830-0025 | Proteasome 19S Rpt4/S10b subunit monoclonal antibody (p42-23) | 25 µl |
| 6590 | BML-PW8830-0100 | Proteasome 19S Rpt4/S10b subunit monoclonal antibody (p42-23) | 100 µl |
| 6591 | BML-PW8835-0025 | Proteasome 19S Rpn12/S14 subunit (human) monoclonal antibody (P31-27) | 25 µl |
| 6592 | BML-PW8835-0100 | Proteasome 19S Rpn12/S14 subunit (human) monoclonal antibody (P31-27) | 100 µl |
| 6593 | BML-PW8840-0025 | Proteasome 20S β1i subunit monoclonal antibody (LMP2 – 13) | 25 µl |
| 6594 | BML-PW8840-0100 | Proteasome 20S β1i subunit monoclonal antibody (LMP2 – 13) | 100 µl |
| 6595 | BML-PW8845-0025 | Proteasome 20S β5i subunit monoclonal antibody (LMP7-1) | 25 µl |
| 6596 | BML-PW8845-0100 | Proteasome 20S β5i subunit monoclonal antibody (LMP7-1) | 100 µl |
| 6597 | BML-PW8850-0100 | PR39 propeptide | 100 µg |
| 6598 | BML-PW8895-0025 | Proteasome 20S β5 subunit (human) polyclonal antibody | 25 µl |
| 6599 | BML-PW8895-0100 | Proteasome 20S β5 subunit (human) polyclonal antibody | 100 µl |
| 6600 | BML-PW8900-0001 | Proteasome 20S (alpha subunits) antibody sampler pack | 8 x 10 µl |
| 6601 | BML-PW8915-0001 | Proteasome activator 11S subunit antibody sampler pack | 3 x 10 µl |
| 6602 | BML-PW8935-0001 | Proteasome 19S (ATPase subunit) antibody sampler pack (human) | 10 x 10 µl |
| 6603 | BML-PW8945-0001 | COP9 signalosome subunits antibody sampler pack | 8 x 10 µl |
| 6604 | BML-PW8950-0001 | Proteasome 26S degradation kit | 96 wells |
| 6605 | BML-PW8960-0001 | Ornithine Decarboxylase and Antizyme pAb pack | 1 Pack |
| 6606 | BML-PW9120-0100 | Proteasome 11S α subunit (human), (recombinant) (GST-tag) | 100 µg |
| 6607 | BML-PW9125-0100 | Proteasome 11S β subunit (human), (recombinant) (GST-tag) | 100 µg |
| 6608 | BML-PW9130-0100 | Proteasome 11S γ subunit (human), (recombinant) (GST-tag) | 100 µg |
| 6609 | BML-PW9140-0025 | Proteasome 20S α4 subunit monoclonal antibody (MCP79) | 25 µl |
| 6610 | BML-PW9140-0100 | Proteasome 20S α4 subunit monoclonal antibody (MCP79) | 100 µl |
| 6611 | BML-PW9150-0025 | Proteasome 20S β7 subunit (human) monoclonal antibody (MCP444) | 25 µl |
| 6612 | BML-PW9150-0100 | Proteasome 20S β7 subunit (human) monoclonal antibody (MCP444) | 100 µl |
| 6613 | BML-PW9250-0025 | Proteasome 19S Rpn10/S5a subunit monoclonal antibody (S5a-18) | 25 µl |
| 6614 | BML-PW9250-0100 | Proteasome 19S Rpn10/S5a subunit monoclonal antibody (S5a-18) | 100 µl |
| 6615 | BML-PW9260-0025 | Proteasome 19S Rpn12/S14 subunit (human) monoclonal antibody (p31-38) | 25 µl |
| 6616 | BML-PW9260-0100 | Proteasome 19S Rpn12/S14 subunit (human) monoclonal antibody (p31-38) | 100 µl |
| 6617 | BML-PW9265-0025 | Proteasome 19S ATPase subunit Rpt6 monoclonal antibody (p45-110) | 25 µl |
| 6618 | BML-PW9265-0100 | Proteasome 19S ATPase subunit Rpt6 monoclonal antibody (p45-110) | 100 µl |
| 6619 | BML-PW9270-0025 | Proteasome 19S Rpn2/S1 subunit (human) monoclonal antibody (112-1) | 25 µl |
| 6620 | BML-PW9270-0100 | Proteasome 19S Rpn2/S1 subunit (human) monoclonal antibody (112-1) | 100 µl |
| 6621 | BML-PW9300-0025 | Proteasome 20S β2 subunit monoclonal antibody (MCP165) | 25 µl |
| 6622 | BML-PW9300-0100 | Proteasome 20S β2 subunit monoclonal antibody (MCP165) | 100 µl |
| 6623 | BML-PW9310-0050 | Proteasome 26S (human), (purified) | 50 µg |
| 6624 | BML-PW9325-0100 | PR11 | 100 µg |
| 6625 | BML-PW9335-0025 | Valosin-containing protein polyclonal antibody | 25 µl |
| 6626 | BML-PW9355-0025 | Proteasome 20S core subunits polyclonal antibody | 25 µl |
| 6627 | BML-PW9355-0100 | Proteasome 20S core subunits polyclonal antibody | 100 µl |
| 6628 | BML-PW9365-0025 | Parkin (human) polyclonal antibody | 25 µl |
| 6629 | BML-PW9365-0100 | Parkin (human) polyclonal antibody | 100 µl |
| 6630 | BML-PW9380-0100 | MCMV pp89 substrate peptide | 100 µg |
| 6631 | BML-PW9385-0025 | Proteasome 20S α2 subunit monoclonal antibody (MCP236) | 25 µl |
| 6632 | BML-PW9390-0001 | Proteasome 20S α6 subunit monoclonal antibody (MCP106) | 1 ml |
| 6633 | BML-PW9395-0025 | Proteasome 20S β7 subunit monoclonal antibody (MCP219) | 25 µl |
| 6634 | BML-PW9400-0025 | Proteasome 19S Rpt1/S7 subunit (human) monoclonal antibody (MSS1-92) | 25 µl |
| 6635 | BML-PW9425-0020 | COP9 signalosome (human), (purified) | 20 µg |
| 6636 | BML-PW9460-0025 | SUMO-1 (human) (CT) polyclonal antibody | 25 µl |
| 6637 | BML-PW9460-0100 | SUMO-1 (human) (CT) polyclonal antibody | 100 µl |
| 6638 | BML-PW9465-0025 | SUMO-2/3 (human) (NT) polyclonal antibody | 25 µl |
| 6639 | BML-PW9465-0100 | SUMO-2/3 (human) (NT) polyclonal antibody | 100 µl |
| 6640 | BML-PW9575-0025 | ISG15 (human) polyclonal antibody | 25 µl |
| 6641 | BML-PW9575-0100 | ISG15 (human) polyclonal antibody | 100 µl |
| 6642 | BML-PW9585-0025 | FAT10 polyclonal antibody | 25 µl |
| 6643 | BML-PW9585-0100 | FAT10 polyclonal antibody | 100 µl |
| 6644 | BML-PW9595-0025 | Urm1 (human) polyclonal antibody | 25 µl |
| 6645 | BML-PW9615-0025 | Fub1 (human) polyclonal antibody | 25 µl |
| 6646 | BML-PW9615-0100 | Fub1 (human) polyclonal antibody | 100 µl |
| 6647 | BML-PW9645-0050 | Immunoproteasome 20S (human), (purified) | 50 µg |
| 6648 | BML-PW9660-0010 | TPPII complex (human), (purified) | 10 µg |
| 6649 | BML-PW9680-0025 | FAT10 polyclonal antibody | 25 µl |
| 6650 | BML-PW9680-0100 | FAT10 polyclonal antibody | 100 µl |
| 6651 | BML-PW9685-0025 | NUB1 (human) polyclonal antibody | 25 µl |
| 6652 | BML-PW9685-0100 | NUB1 (human) polyclonal antibody | 100 µl |
| 6653 | BML-PW9705-0025 | HERP (human) polyclonal antibody | 25 µl |
| 6654 | BML-PW9705-0100 | HERP (human) polyclonal antibody | 100 µl |
| 6655 | BML-PW9710-0025 | PI31 polyclonal antibody | 25 µl |
| 6656 | BML-PW9710-0100 | PI31 polyclonal antibody | 100 µl |
| 6657 | BML-PW9715-0025 | POMP polyclonal antibody | 25 µl |
| 6658 | BML-PW9715-0100 | POMP polyclonal antibody | 100 µl |
| 6659 | BML-PW9720-0025 | COP9 signalosome Csn2 subunit (mouse) polyclonal antibody | 25 µl |
| 6660 | BML-PW9725-0025 | COP1 polyclonal antibody | 25 µl |
| 6661 | BML-PW9725-0100 | COP1 polyclonal antibody | 100 µl |
| 6662 | BML-PW9780-0025 | Ub<sup>+1</sup> polyclonal antibody | 25 µl |
| 6663 | BML-PW9780-0100 | Ub<sup>+1</sup> polyclonal antibody | 100 µl |
| 6664 | BML-PW9790-0100 | PR26 | 100 µg |
| 6665 | BML-PW9795-0025 | USP15 (human) polyclonal antibody | 25 µl |
| 6666 | BML-PW9795-0100 | USP15 (human) polyclonal antibody | 100 µl |
| 6667 | BML-PW9860-0025 | p62 (human) polyclonal antibody | 25 µl |
| 6668 | BML-PW9860-0100 | p62 (human) polyclonal antibody | 100 µl |
| 6669 | BML-PW9865-0100 | Proteasome activator 11S α subunit (human), (recombinant) | 100 µg |
| 6670 | BML-PW9870-0100 | Proteasome activator 11S β subunit (human), (recombinant) | 100 µg |
| 6671 | BML-PW9875-0100 | Proteasome activator 11S γ subunit (human), (recombinant) | 100 µg |
| 6672 | BML-PW9901-0001 | Proteasome inhibitor pack | 1 Pack |
| 6673 | BML-PW9905-0001 | Proteasome substrate pack | 1 Pack |
| 6674 | BML-RA101-0010 | LY 171883 | 10 mg |
| 6675 | BML-RA101-0050 | LY 171883 | 50 mg |
| 6676 | BML-RA102-0100 | U-75302 | 100 µg |
| 6677 | BML-RA103-0001 | SQ-29548 | 1 mg |
| 6678 | BML-RA104-0010 | Picotamide | 10 mg |
| 6679 | BML-RA104-0050 | Picotamide | 50 mg |
| 6680 | BML-RA105-0001 | Fluprostenol | 1 mg |
| 6681 | BML-RA105-0010 | Fluprostenol | 10 mg |
| 6682 | BML-RA108-0001 | BML-111 | 1 mg |
| 6683 | BML-RA108-0005 | BML-111 | 5 mg |
| 6684 | BML-RA109-0005 | MK-571 . sodium salt | 5 mg |
| 6685 | BML-RA109-0025 | MK-571 . sodium salt | 25 mg |
| 6686 | BML-RA110-0005 | AH-6809 | 5 mg |
| 6687 | BML-RA110-0025 | AH-6809 | 25 mg |
| 6688 | BML-RA112-0005 | SC-51322 | 5 mg |
| 6689 | BML-RA112-0025 | SC-51322 | 25 mg |
| 6690 | BML-RA113-0005 | SC-51089 | 5 mg |
| 6691 | BML-RA113-0025 | SC-51089 | 25 mg |
| 6692 | BML-RA114-1000 | BAY-u9773 | 1 mg |
| 6693 | BML-RA115-0005 | LY-255283 | 5 mg |
| 6694 | BML-RA116-0001 | Sulprostone | 1 mg |
| 6695 | BML-RA116-0005 | Sulprostone | 5 mg |
| 6696 | BML-RA117-0005 | L-655,240 | 5 mg |
| 6697 | BML-RA118-0005 | L-161-982 | 5 mg |
| 6698 | BML-RA119-0010 | Seratrodast | 10 mg |
| 6699 | BML-RA119-0050 | Seratrodast | 50 mg |
| 6700 | BML-RA120-0001 | Latanoprost | 1 mg |
| 6701 | BML-RA120-0005 | Latanoprost | 5 mg |
| 6702 | BML-RA121-0001 | Bimatoprost | 1 mg |
| 6703 | BML-RA121-0010 | Bimatoprost | 10 mg |
| 6704 | BML-S104-0005 | Conduritol B Epoxide | 5 mg |
| 6705 | BML-S104-0025 | Conduritol B Epoxide | 25 mg |
| 6706 | BML-S107-0100 | Castanospermine | 100 mg |
| 6707 | BML-S107-0500 | Castanospermine | 500 mg |
| 6708 | BML-S108-0005 | Deoxyfuconojirimycin . hydrochloride | 5 mg |
| 6709 | BML-S109-0005 | Deoxymannojirimycin . HCl | 5 mg |
| 6710 | BML-S112-0001 | Swainsonine | 1 mg |
| 6711 | BML-S112-0005 | Swainsonine | 5 mg |
| 6712 | BML-S114-0001 | Kifunensine | 1 mg |
| 6713 | BML-S114-0005 | Kifunensine | 5 mg |
| 6714 | BML-S115-0001 | Mannostatin A . HCl | 1 mg |
| 6715 | BML-S180-0005 | Coumestrol | 5 mg |
| 6716 | BML-S180-0025 | Coumestrol | 25 mg |
| 6717 | BML-S200-0010 | U-18666A | 10 mg |
| 6718 | BML-S200-0050 | U-18666A | 50 mg |
| 6719 | BML-S510-0025 | Mifepristone | 25 mg |
| 6720 | BML-S510-0100 | Mifepristone | 100 mg |
| 6721 | BML-S515-0001 | Megestrol acetate | 1 g |
| 6722 | BML-S520-0200 | Melengestrol acetate | 200 mg |
| 6723 | BML-S520-1000 | Melengestrol acetate | 1 g |
| 6724 | BML-S540-0010 | 2-Methoxyestradiol | 10 mg |
| 6725 | BML-S540-0050 | 2-Methoxyestradiol | 50 mg |
| 6726 | BML-S620-0020 | Pregnenolone-16α-carbonitrile | 20 mg |
| 6727 | BML-S620-0100 | Pregnenolone-16α-carbonitrile | 100 mg |
| 6728 | BML-S701-0010 | SDZ-089443 | 10 mg |
| 6729 | BML-S701-0050 | SDZ-089443 | 50 mg |
| 6730 | BML-SA1100-0025 | 7B2 polyclonal antibody | 25 µl |
| 6731 | BML-SA1100-0100 | 7B2 polyclonal antibody | 100 µl |
| 6732 | BML-SA111-0200 | EGF receptor (human) monoclonal antibody (F4) | 200 µg |
| 6733 | BML-SA113-0200 | Na<sup>+</sup>/K<sup>+</sup> ATPase polyclonal antibody | 200 µg |
| 6734 | BML-SA115-0010 | Catalase polyclonal antibody | 10 mg |
| 6735 | BML-SA119-0100 | CDK1 monoclonal antibody (17) | 100 µg |
| 6736 | BML-SA124-0100 | Retinoblastoma protein (human) monoclonal antibody (1F8) | 100 µg |
| 6737 | BML-SA125-0050 | G protein β subunit (internal) polyclonal antibody | 50 µl |
| 6738 | BML-SA1264-0025 | Serotonin polyclonal antibody | 25 µl |
| 6739 | BML-SA1264-0100 | Serotonin polyclonal antibody | 100 µl |
| 6740 | BML-SA1267-0025 | Somatostatin 14 polyclonal antibody | 25 µl |
| 6741 | BML-SA1267-0100 | Somatostatin 14 polyclonal antibody | 100 µl |
| 6742 | BML-SA1270-0025 | Substance P polyclonal antibody | 25 µl |
| 6743 | BML-SA1270-0100 | Substance P polyclonal antibody | 100 µl |
| 6744 | BML-SA127-0050 | G protein α<sub>i1</sub> subunit polyclonal antibody | 50 µl |
| 6745 | BML-SA128-0050 | G protein α<sub>i1</sub> and α<sub>i2</sub> subunits polyclonal antibody | 50 µl |
| 6746 | BML-SA129-0050 | G protein α<sub>i3</sub> subunit polyclonal antibody | 50 µl |
| 6747 | BML-SA130-0050 | G protein α<sub>i3</sub> and α<sub>0</sub> subunits polyclonal antibody | 50 µl |
| 6748 | BML-SA131-0050 | G protein α<sub>s</sub> subunit polyclonal antibody | 50 µl |
| 6749 | BML-SA133-0100 | Cyclophilin 40 (CT) polyclonal antibody | 100 µl |
| 6750 | BML-SA134-0100 | Cyclophilin 40 polyclonal antibody | 100 µl |
| 6751 | BML-SA136-0100 | FKBP59 polyclonal antibody | 100 µg |
| 6752 | BML-SA144-0100 | PKCα polyclonal antibody | 100 µg |
| 6753 | BML-SA146-0001 | PKCβII polyclonal antibody | 1 ml |
| 6754 | BML-SA147-0001 | PKCγ polyclonal antibody | 1 ml |
| 6755 | BML-SA149-0100 | PKCε polyclonal antibody | 100 µl |
| 6756 | BML-SA154-0100 | Phosphotyrosine polyclonal antibody | 100 µg |
| 6757 | BML-SA158-0100 | Retinoic acid receptor β polyclonal antibody | 100 µl |
| 6758 | BML-SA163-0100 | Casein kinase II α subunit monoclonal antibody (1AD9) | 100 µg |
| 6759 | BML-SA170-0100 | NF-κB (p50) (human) (NT) polyclonal antibody | 100 µl |
| 6760 | BML-SA171-0100 | NF-κB (p65) (CT) polyclonal antibody | 100 µl |
| 6761 | BML-SA172-0100 | NF-κB c-rel (human) polyclonal antibody | 100 µl |
| 6762 | BML-SA182-0001 | G Protein antibody set | 1 Set |
| 6763 | BML-SA188-0100 | Retinoblastoma protein monoclonal antibody (MAb245) | 100 µg |
| 6764 | BML-SA189-0100 | Retinoblastoma protein (under-phosphorylated) monoclonal antibody (MAb549) | 100 µg |
| 6765 | BML-SA193-0100 | CDK2 polyclonal antibody | 100 µl |
| 6766 | BML-SA195-0250 | Protein kinase A RII subunit monoclonal antibody (R-30) | 250 µg |
| 6767 | BML-SA200-0025 | Nitric oxide synthase (inducible) polyclonal antibody | 25 µl |
| 6768 | BML-SA200-0100 | Nitric oxide synthase (inducible) polyclonal antibody | 100 µl |
| 6769 | BML-SA204-0100 | Goat anti-mouse IgG, (HRP conjugate) | 100 µg |
| 6770 | BML-SA208-0100 | CDK1 polyclonal antibody | 100 µl |
| 6771 | BML-SA210-0025 | Aryl hydrocarbon receptor polyclonal antibody | 25 µg |
| 6772 | BML-SA210-0100 | Aryl hydrocarbon receptor polyclonal antibody | 100 µg |
| 6773 | BML-SA213-0100 | ZIP kinase polyclonal antibody | 100 µg |
| 6774 | BML-SA214-0100 | Smac/DIABLO polyclonal antibody | 100 µg |
| 6775 | BML-SA216-0100 | Poly(ADP-ribose) monoclonal antibody | 100 µl |
| 6776 | BML-SA219-0100 | Smac/DIABLO polyclonal antibody | 100 µg |
| 6777 | BML-SA225-0100 | TRAIL-R1 polyclonal antibody | 100 µg |
| 6778 | BML-SA227-0025 | nNOS polyclonal antibody | 25 µg |
| 6779 | BML-SA227-0100 | nNOS polyclonal antibody | 100 µg |
| 6780 | BML-SA230-0100 | Apoptosis-inducing factor (human) polyclonal antibody | 100 µg |
| 6781 | BML-SA232-0050 | G protein α<sub>q/11</sub> subunit polyclonal antibody | 50 µl |
| 6782 | BML-SA235-0100 | RARγ1 polyclonal antibody | 100 µl |
| 6783 | BML-SA237-0025 | COX-2 polyclonal antibody | 25 µg |
| 6784 | BML-SA237-0100 | COX-2 polyclonal antibody | 100 µg |
| 6785 | BML-SA239-0100 | Bcl-2 (human) monoclonal antibody (4D7) | 100 µg |
| 6786 | BML-SA240-1000 | Phosphotyrosine monoclonal antibody (PY20) | 1 mg |
| 6787 | BML-SA241-0500 | Phosphotyrosine monoclonal antibody (PY20) (agarose immobilized) | 0.5 ml |
| 6788 | BML-SA242-0100 | Phosphotyrosine monoclonal antibody (PY20) (FITC conjugate) | 100 µg |
| 6789 | BML-SA243-0100 | Phosphotyrosine monoclonal antibody (PY20) (biotin conjugate) | 100 µg |
| 6790 | BML-SA247-0100 | Na<sup>+</sup>/K<sup>+ </sup>ATPase α3 subunit monoclonal antibody (XVIF9-G10) | 100 µg |
| 6791 | BML-SA249-0050 | PARP-1 monoclonal antibody (C-2-10) (affinity purified) | 50 µg |
| 6792 | BML-SA250-0050 | PARP-1 monoclonal antibody (C-2-10) | 50 µl |
| 6793 | BML-SA253-0025 | PARP polyclonal antibody | 25 µl |
| 6794 | BML-SA253-0100 | PARP polyclonal antibody | 100 µl |
| 6795 | BML-SA254-0100 | IP3 receptor type 1 polyclonal antibody | 100 µl |
| 6796 | BML-SA255-0100 | m-Calpain (domain III/IV) monoclonal antibody (107-82) | 100 µl |
| 6797 | BML-SA259-0100 | TRAIL (human) polyclonal antibody | 100 µg |
| 6798 | BML-SA262-0100 | Cyclin D2 monoclonal antibody (blocking) (DCS-3.1) | 100 µg |
| 6799 | BML-SA263-0100 | Cyclin D2 monoclonal antibody (DCS-5.2) | 100 µg |
| 6800 | BML-SA265-0100 | Cyclin D3 monoclonal antibody (DCS-28.1) | 100 µg |
| 6801 | BML-SA266-0020 | [pThr<sup>180</sup>/pTyr<sup>182</sup>]p38 polyclonal antibody | 20 µl |
| 6802 | BML-SA268-0100 | Leptin polyclonal antibody | 100 µg |
| 6803 | BML-SA270-0100 | PKA RIIβ subunit polyclonal antibody | 100 µl |
| 6804 | BML-SA272-0020 | [pThr<sup>183</sup>/pTyr<sup>185</sup>]JNK1/2 polyclonal antibody | 20 µl |
| 6805 | BML-SA272-0100 | [pThr<sup>183</sup>/pTyr<sup>185</sup>]JNK1/2 polyclonal antibody | 100 µl |
| 6806 | BML-SA273-0100 | CDK4 monoclonal antibody (35.1) | 100 µg |
| 6807 | BML-SA275-0020 | [pThr<sup>185</sup>/pTyr<sup>187</sup>]ERK1/2 polyclonal antibody | 20 µl |
| 6808 | BML-SA275-0100 | [pThr<sup>185</sup>/pTyr<sup>187</sup>]ERK1/2 polyclonal antibody | 100 µl |
| 6809 | BML-SA279-0005 | [pSer<sup>392</sup>]p53 polyclonal antibody | 5 µg |
| 6810 | BML-SA279-0025 | [pSer<sup>392</sup>]p53 polyclonal antibody | 25 µg |
| 6811 | BML-SA281-0100 | G protein α<sub>i1</sub> subunit monoclonal antibody (R4.5) | 100 µg |
| 6812 | BML-SA285-0200 | PKA RIα subunit polyclonal antibody | 200 µg |
| 6813 | BML-SA287-0100 | HIF-1α monoclonal antibody (H1α67) | 100 µl |
| 6814 | BML-SA289-0100 | HIF-1α monoclonal antibody (OZ12) | 100 µg |
| 6815 | BML-SA293-0050 | p53 monoclonal antibody (PAb421) | 50 µg |
| 6816 | BML-SA296-0100 | Cyclophilin A polyclonal antibody | 100 µl |
| 6817 | BML-SA297-0100 | Nitrotyrosine polyclonal antibody | 100 µl |
| 6818 | BML-SA298-0050 | Bak (human) monoclonal antibody (TC100) | 50 µg |
| 6819 | BML-SA320-0100 | Caspase-3 (human) polyclonal antibody | 100 µl |
| 6820 | BML-SA324-0100 | Caspase-11 (mouse) polyclonal antibody | 100 µl |
| 6821 | BML-SA326-0100 | Caspase-4 (human) polyclonal antibody | 100 µl |
| 6822 | BML-SA328-0020 | [pTyr<sup>705</sup>]STAT3 polyclonal antibody | 20 µl |
| 6823 | BML-SA328-0100 | [pTyr<sup>705</sup>]STAT3 polyclonal antibody | 100 µl |
| 6824 | BML-SA329-0040 | [pTyr<sup>701</sup>]STAT1 (mouse) polyclonal antibody | 40 µl |
| 6825 | BML-SA330-0010 | [pTyr<sup>701</sup>]STAT1 (human) polyclonal antibody | 10 µg |
| 6826 | BML-SA3400-0025 | α-Synuclein polyclonal antibody | 25 µl |
| 6827 | BML-SA3400-0100 | α-Synuclein polyclonal antibody | 100 µl |
| 6828 | BML-SA3405-0025 | β-Synuclein polyclonal antibody | 25 µl |
| 6829 | BML-SA3405-0100 | β-Synuclein polyclonal antibody | 100 µl |
| 6830 | BML-SA342-0010 | [pTyr<sup>407</sup>]Focal adhesion kinase polyclonal antibody | 10 µg |
| 6831 | BML-SA342-0050 | [pTyr<sup>407</sup>]Focal adhesion kinase polyclonal antibody | 50 µg |
| 6832 | BML-SA343-0010 | [pTyr<sup>576</sup>]Focal adhesion kinase polyclonal antibody | 10 µg |
| 6833 | BML-SA344-0050 | [pTyr<sup>845</sup>]EGF receptor (human) monoclonal antibody (12A3) | 50 µg |
| 6834 | BML-SA347-0010 | MEK7 (human) monoclonal antibody (3F5) | 10 µg |
| 6835 | BML-SA347-0050 | MEK7 (human) monoclonal antibody (3F5) | 50 µg |
| 6836 | BML-SA349-0010 | [pTyr<sup>317</sup>]Shc monoclonal antibody (15E11) | 10 µg |
| 6837 | BML-SA354-0100 | Cathepsin G (human) polyclonal antibody | 100 µl |
| 6838 | BML-SA355-0100 | Cathepsin H (human) polyclonal antibody | 100 µl |
| 6839 | BML-SA360-0020 | [pThr<sup>246</sup>]PRAS40 (human) polyclonal antibody | 20 µl |
| 6840 | BML-SA360-0100 | [pThr<sup>246</sup>]PRAS40 (human) polyclonal antibody | 100 µl |
| 6841 | BML-SA361-0100 | Cathepsin B (human) polyclonal antibody | 100 µl |
| 6842 | BML-SA362-0100 | Cathepsin L (human) polyclonal antibody | 100 µl |
| 6843 | BML-SA365-0020 | [pTyr<sup>783</sup>]Phospholipase Cγ-1 polyclonal antibody | 20 µl |
| 6844 | BML-SA365-0100 | [pTyr<sup>783</sup>]Phospholipase Cγ-1 polyclonal antibody | 100 µl |
| 6845 | BML-SA366-0020 | [pTyr<sup>340/341</sup>]c-Raf-1 polyclonal antibody | 20 µl |
| 6846 | BML-SA366-0100 | [pTyr<sup>340/341</sup>]c-Raf-1 polyclonal antibody | 100 µl |
| 6847 | BML-SA367-0100 | [pSer<sup>249</sup>/pThr<sup>252</sup>]Retinoblastoma protein (human) polyclonal antibody | 100 µl |
| 6848 | BML-SA368-0020 | [pThr<sup>821</sup>]Retinoblastoma protein (human) polyclonal antibody | 20 µl |
| 6849 | BML-SA368-0100 | [pThr<sup>821</sup>]Retinoblastoma protein (human) polyclonal antibody | 100 µl |
| 6850 | BML-SA369-0100 | Insulin-like growth factor-1 receptor monoclonal antibody (1-2) | 100 µg |
| 6851 | BML-SA375-0100 | TIMP-3 (human) polyclonal antibody | 100 µg |
| 6852 | BML-SA376-0100 | ADAM9 polyclonal antibody | 100 µg |
| 6853 | BML-SA377-0100 | ADAM10 (human) polyclonal antibody | 100 µg |
| 6854 | BML-SA380-0100 | TIMP-4 polyclonal antibody | 100 µg |
| 6855 | BML-SA381-0020 | [pSer<sup>383</sup>]Elk1 polyclonal antibody | 20 µl |
| 6856 | BML-SA381-0100 | [pSer<sup>383</sup>]Elk1 polyclonal antibody | 100 µl |
| 6857 | BML-SA382-0100 | [pSer<sup>152/156</sup>]MARCKS polyclonal antibody | 100 µl |
| 6858 | BML-SA383-0020 | [pSer<sup>218/222</sup>]MEK1/2 (human) polyclonal antibody | 20 µl |
| 6859 | BML-SA383-0100 | [pSer<sup>218/222</sup>]MEK1/2 (human) polyclonal antibody | 100 µl |
| 6860 | BML-SA392-0020 | [pTyr<sup>1158/1162/1163</sup>]Insulin receptor and [pTyr<sup>1131/1135/1136</sup>]IGF-1 Receptor polyclonal antibody | 20 µl |
| 6861 | BML-SA392-0100 | [pTyr<sup>1158/1162/1163</sup>]Insulin receptor and [pTyr<sup>1131/1135/1136</sup>]IGF-1 Receptor polyclonal antibody | 100 µl |
| 6862 | BML-SA393-0020 | [pTyr<sup>1229</sup>]Insulin receptor substrate 1 (human) polyclonal antibody | 20 µl |
| 6863 | BML-SA394-0020 | [pTyr<sup>941</sup>]Insulin receptor substrate 1 (human) polyclonal antibody | 20 µl |
| 6864 | BML-SA399-0020 | [pThr<sup>71</sup>]Activating transcription factor 2 (human) polyclonal antibody | 20 µl |
| 6865 | BML-SA399-0100 | [pThr<sup>71</sup>]Activating transcription factor 2 (human) polyclonal antibody | 100 µl |
| 6866 | BML-SA401-0100 | HDAC1 polyclonal antibody | 100 µg |
| 6867 | BML-SA402-0100 | HDAC2 polyclonal antibody | 100 µg |
| 6868 | BML-SA403-0100 | HDAC3 polyclonal antibody | 100 µg |
| 6869 | BML-SA404-0100 | HDAC4 polyclonal antibody | 100 µg |
| 6870 | BML-SA405-0020 | [pSer<sup>52</sup>]Eukaryotic Initiation factor 2 α polyclonal antibody | 20 µl |
| 6871 | BML-SA405-0100 | [pSer<sup>52</sup>]Eukaryotic Initiation factor 2 α polyclonal antibody | 100 µl |
| 6872 | BML-SA411-0100 | ADAMTS5 polyclonal antibody | 100 µg |
| 6873 | BML-SA412-0020 | [pSer<sup>32/36</sup>]IκBα polyclonal antibody | 20 µl |
| 6874 | BML-SA412-0100 | [pSer<sup>32/36</sup>]IκBα polyclonal antibody | 100 µl |
| 6875 | BML-SA416-0100 | [pSer<sup>181</sup>]TAO2 polyclonal antibody | 100 µl |
| 6876 | BML-SA418-0100 | [pTyr<sup>1472</sup>]NMDA receptor NR2B subunit (rat) polyclonal antibody | 100 µl |
| 6877 | BML-SA420-0050 | GABAA receptor γ2 polyclonal antibody | 50 µl |
| 6878 | BML-SA423-0500 | Cyclin E polyclonal antibody | 500 µg |
| 6879 | BML-SA424-0100 | GABAA receptor γ2 (CT loop) polyclonal antibody | 100 µl |
| 6880 | BML-SA425-0050 | NMDA receptor NR2A subunit polyclonal antibody | 50 µl |
| 6881 | BML-SA426-0050 | NMDA receptor NR2B subunit polyclonal antibody | 50 µl |
| 6882 | BML-SA427-0100 | SIRT1 (human) polyclonal antibody | 100 µl |
| 6883 | BML-SA428-0100 | ADAM15 polyclonal antibody | 100 µg |
| 6884 | BML-SA429-0100 | ZAP-70 (human) polyclonal antibody | 100 µg |
| 6885 | BML-SA430-0500 | Focal adhesion kinase polyclonal antibody | 500 µg |
| 6886 | BML-SA432-0100 | Insulin receptor β subunit monoclonal antibody (CT-3) | 100 µg |
| 6887 | BML-SA433-0020 | [pTyr<sup>397</sup>]Focal adhesion kinase polyclonal antibody | 20 µl |
| 6888 | BML-SA433-0100 | [pTyr<sup>397</sup>]Focal adhesion kinase polyclonal antibody | 100 µl |
| 6889 | BML-SA434-0100 | Matrix metalloproteinase 10 (human) (hinge region) polyclonal antibody | 100 µg |
| 6890 | BML-SA439-0020 | [pThr<sup>98</sup>]Myelin basic protein monoclonal antibody (P12) | 20 µg |
| 6891 | BML-SA439-0100 | [pThr<sup>98</sup>]Myelin basic protein monoclonal antibody (P12) | 100 µg |
| 6892 | BML-SA447-0100 | Kallikrein-1 (human) polyclonal antibody | 100 µg |
| 6893 | BML-SA448-0100 | Kallikrein-2 (human) polyclonal antibody | 100 µg |
| 6894 | BML-SA452-0100 | [K(Ac)<sup>40</sup>]α-Tubulin polyclonal antibody | 100 µl |
| 6895 | BML-SA461-0100 | ACE1 (human) (NT) polyclonal antibody | 100 µg |
| 6896 | BML-SA462-0100 | ACE1 (human) (CT) polyclonal antibody | 100 µg |
| 6897 | BML-SA464-0100 | SIRT5 polyclonal antibody | 100 µl |
| 6898 | BML-SA465-0100 | BACE1 polyclonal antibody | 100 µg |
| 6899 | BML-SA467-0100 | MMP-12 (CT) polyclonal antibody | 100 µg |
| 6900 | BML-SA468-0100 | Nitrotyrosine monoclonal antibody (HM11) | 100 µg |
| 6901 | BML-SA470-0100 | ADAM12 (catalytic domain) (human) polyclonal antibody | 100 µl |
| 6902 | BML-SA474-0025 | 14-3-3β polyclonal antibody | 25 µl |
| 6903 | BML-SA474-0100 | 14-3-3β polyclonal antibody | 100 µl |
| 6904 | BML-SA475-0025 | 14- |